Results 61 to 70 of about 1,041,462 (205)

Intrarenal Resistance Index as a Prognostic Parameter in Patients with Liver Cirrhosis Compared with Other Hepatic Scoring Systems [PDF]

, 2012
Background and Aims: Patients with advanced liver cirrhosis who develop renal dysfunction have a poor prognosis. Elevated intrarenal resistance indices (RIs) due to renal vascular constriction have been described before in cirrhotic patients.
Kaiser, C., M. Götzberger, C. Kaiser, J. Singer, V. Gülberg, Gülberg, Veit, Singer, J., Götzberger, M.   +7 more
core   +1 more source

CLINICAL EFFICACY OF ALBUMIN DIALYSIS THERAPY FOR PATIENTS WITH HEPATORENAL SYNDROME

Вестник трансплантологии и искусственных органов, 2009
34 patients (23 male, 11 female) in the age of 41–77 years (mean age 59,7 ± 4,2 years) with 2 type hepatorenal syndrome were included in the study. All patients were divided in 3 groups.
D. E. Kutepov, I. N. Pasechnik, N. P. Mironov, E. V. Tsygankov, A. V. Popov, O. K. Morochova, S. V. Stebletsov, E. Y. Kotselapova, M. G. Vershinina   +8 more
doaj   +1 more source

Therapeutic Properties and Underlying Mechanisms of Traditional Chinese Medicine in Managing Rheumatoid Arthritis: An Integrative Review of Clinical and Molecular Findings

Phytotherapy Research, EarlyView.
The translational research framework integrating TCM for RA. The figure outlines a stepwise framework for the modernization and clinical translation of TCM in RA. Part 1 highlights the inheritance and development of TCM theory, including classical medical texts, traditional herbal knowledge, and syndrome differentiation–based treatment principles. Part
Jianting Wen, Jian Liu, Lei Wan, Fanfan Wang, Yang Li   +4 more
wiley   +1 more source

Type 1 Hepatorenal Syndrome [PDF]

, 2016
Type 1 hepatorenal syndrome is kidney failure that occurs in advanced cirrhosis (Fagundes & Ginès, 2012). It is characterized by a, “significant reduction in creatinine clearance within 1-2 weeks of presentation” (Bacon, 2015). Patients that develop this
Evans, Ernest
core  

Terlipressin for hepatorenal syndrome

, 2012
Clinical trials suggest that terlipressin improves renal function in hepatorenal syndrome, but the evidence concerning mortality is ...
Kurt Christensen, Christensen, Kurt, Aleksander Krag, Gluud, Lise Lotte, Lise Lotte Gluud, Erik Christensen, Christensen, Erik, Krag, Aleksander   +7 more
core   +1 more source

Role of human albumin in the management of liver cirrhosis

Медицинский совет, 2020
Aim. To demonstrate the role of concentrated human albumin in cirrhotic patient management.The main content. Albumin has a clear place in the clinical practice of cirrhotic patients managing.
M. V. Maevskaya, M. S. Zharkova
doaj   +1 more source

Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cirrhosis: A Multicentre National Study

Alimentary Pharmacology &Therapeutics, EarlyView.
Summary of a multicentre TriNetX study evaluating outcomes after percutaneous coronary intervention (PCI) in patients with cirrhosis. Cirrhosis was associated with higher 1‐year gastrointestinal bleeding and mortality, especially with decompensated disease.
Dhir Gala, Sameer Rao, Manas Gunani, Kajol Shah, Anand V. Kulkarni, Karn Wijarnpreecha, Daniel Q. Huang, Pojsakorn Danpanichkul, Ahmed Al‐Khazraji, Kaveh Hajifathalian, Vivek Lingiah, Paul Gaglio, Nikki Duong, Christine Gerula   +13 more
wiley   +1 more source

Hepatorenal Syndrome Type 1: Current Challenges And Future Prospects

, 2019
Antonio Facciorusso Gastroenterology Unit, University of Foggia, Foggia, ItalyCorrespondence: Antonio FacciorussoGastroenterology Unit, Department of Medical Sciences, University of Foggia, AOU Ospedali Riuniti, Viale Pinto, 1, Foggia 71100, ItalyTel +39
Facciorusso A
core   +1 more source

Recombinant ADAMTS13 Ameliorates Liver Injury and Improves Hepatic Microcirculation in a Murine Acute‐on‐Chronic Liver Failure Model

Hepatology Research, EarlyView.
ABSTRACT Aim The therapeutic significance of recombinant a disintegrin‐like and metalloprotease with thrombospondin type 1 motif 13 (rADAMTS13) in acute‐on‐chronic liver failure (ACLF) remains unclear. We aimed to investigate the therapeutic effects of rADAMTS13 in a murine model of ACLF‐like liver injury.
Jun‐ichi Hanatani, Norihisa Nishimura, Kosuke Kaji, Masayoshi Takami, Hiroyuki Masuda, Hiroaki Takaya, Koh Kitagawa, Shinya Sato, Tadashi Namisaki, Hitoshi Yoshiji   +9 more
wiley   +1 more source

Serum microRNA-122 predicts survival in patients with liver cirrhosis [PDF]

, 2012
Background: Liver cirrhosis is associated with high morbidity and mortality. MicroRNAs (miRs) circulating in the blood are an emerging new class of biomarkers.
Stefan Zeuzem, Albrecht Piiper (22854), Oliver Waidmann, Kronenberger, Bernd, Friederike Brunner, Verena Köberle (130993), Bernd Kronenberger (131004), Bernd Kronenberger, Verena Köberle, Waidmann, Oliver, Albrecht Piiper, Oliver Waidmann (130988), Piiper, Albrecht, Friederike Brunner (130998), Köberle, Verena, Brunner, Friederike, Zeuzem, Stefan, Stefan Zeuzem (22856)   +17 more
core   +2 more sources